Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Irish Journal of Medical Science (1971 -)
Published in: Irish Journal of Medical Science (1971 -) 4/2015

01-12-2015 | Original Article

Effects of percutaneous coronary intervention on the ambulatory blood pressure of patients with hypertension and coronary heart disease

Authors: Jing Yang, Xuming Yang, Wei Liu, Tingting Cao

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2015

Login to get access

Abstract

Objective

The aim of this study was to investigate the dynamic characteristics and changing trends of ambulatory blood pressure in patients with hypertension and coronary heart disease before and after percutaneous coronary intervention (PCI), and to determine the effects of PCI on the ambulatory blood pressure of patients with hypertension and coronary heart disease.

Methods

A total of 126 patients with hypertension and unstable angina and who were hospitalized and received complete revascularization were enrolled in the study. The ambulatory blood pressure of the patients was monitored at three time points: 1–3 days before PCI (baseline), 3–6 days after PCI (1 week) and 1 month after PCI (1 month). The parameters between the time points were then compared using a t test.

Results

Each ambulatory blood pressure index after PCI was not statistically different from those before PCI (P > 0.05). However, 1 month after the PCI, all ambulatory blood pressure indices significantly decreased and statistically differed from those before PCI (P < 0.01).

Conclusion

PCI can significantly improve the autonomic nerve function and ambulatory blood pressure indices of patients with hypertension and coronary heart disease.
Literature
1.
Messerli FH, Panjrath GS (2009) The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol. 54:1827–1834CrossRefPubMed
2.
Cahan A, Ben-Dov IZ, Bursztyn M (2012) Association of heart rate with blood pressure variability: implications for blood pressure measurement. Am J Hypertens 25:313–318CrossRefPubMed
3.
Wang G (2006) Effects of impaired glucose metabolism on heart rate variability and blood pressure variability in essential hypertensive patients. Huazhong Univ Sci Technol Med Sci 26:654–656CrossRef
4.
Fagard RH, Pardaens K, Staessen JA (2001) Relationships of heart rate and heart rate variability with conventional and ambulatory blood pressure in the population. J Hypertens 19:389–397CrossRefPubMed
5.
Mancia G, De Backer G, Dominiczak A (2007) 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 12:1462–1536
6.
Furukawa T, Hatsuno T, Ueno Y et al (2009) Relationship between decrease in ambulatory blood pressure and heart rate variability due to the effects of taking olmesartan medoxomil. Clin Drug Investig 29:257–264CrossRefPubMed
7.
Milovanovic B, Trifunovic D, Djuric D (2011) Autonomic nervous system adjustment (ANSA) in patients with hypertension treated with enalapril. Acta Physiol Hung 98:71–84CrossRefPubMed
8.
Uen S, Un I, Fimmers R et al (2006) Myocardial ischemia during everyday life in patients with arterial hypertension: prevalence, risk factors, triggering mechanism and circadian variability. Blood Pressure Monit 11:173–182CrossRef
9.
Fagard RH, Celis H, Thijs L et al (2008) Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 51(1):55–61CrossRefPubMed
10.
Habibzadeh MR, Farzaneh-Far R, Sarna P et al (2010) Association of blood pressure and heart rate response during exercise with cardiovascular events in the Heart and Soul Study. J Hypertens 28:2236–2242CrossRefPubMed
11.
Kunz VC, Souza RB, Takahashi AC et al (2011) The relationship between cardiac autonomic function and clinical and angiographic characteristics in patients with coronary artery disease. Rev Bras Fisioter 15:503–510CrossRefPubMed
12.
Hallas CN, Thornton EW, Fabri BM et al (2003) Predicting blood pressure reactivity and heart rate variability from mood state following coronary artery bypass surgery. Int J Psychophysiol 47:43–55CrossRefPubMed
13.
Cabezas-Cerrato J, Hermida RC, Cabezas-Agricola JM et al (2009) Cardiac autonomic neuropathy, estimated cardiovascular risk, and circadian blood pressure pattern in diabetes mellitus. Chronobiol Int 26:942–957CrossRefPubMed
14.
Larosa C, Sgueglia GA, Sestito A et al (2008) Predictors of impaired heart rate variability and clinical outcome in patients with acute myocardial infarction treated by primary angioplasty. J Cardiovasc Med (Hagerstown) 9:76–80CrossRef
15.
Spalding TW, Lyon LA, Steel DH et al (2004) Aerobic exercise training and cardiovascular reactivity to psychological stress in sedentary young normotensive men and women. Psychophysiology 41:552–562CrossRefPubMed
16.
Szydlo K, Wita K, Trusz-Gluza M et al (2008) Impact of left ventricular remodeling on ventricular repolarization and heart rate variability inpatients after myocardial infarction treated with primary PCI: prospective 6 months follow-up. Ann Noninvasive Electrocardiol 13:8–13CrossRefPubMed
17.
Sedziwy E, Olszowska M, Tracz W et al (2002) Heart rate variability in patients treated with percutaneous transluminal coronary angioplasty. Acta Cardiol 57:70–71PubMed
18.
Ebbs D (2001) A comparison of selected antihypertensives and the use of conventional vs ambulatory blood pressure in the detection and treatment of hypertension. J Cardiol 96:3–9CrossRef
19.
Koharo K, Nishida W, Maguchi M, et al (1995) Autonomic nervous function in non-dipper essential hypertensive subjects evaluation by power spectral analysis of heart rate variability. Hypertension 26:808–814
20.
Rechciński T, Trzos E, Wierzbowska-Drabik K et al (2010) Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability. Hypertens Res 33:56–61CrossRefPubMed
21.
Yutaka I, Takayoshi O, Kei A et al (2004) Epidemiology of hypertension based on ambulatory blood pressure monitoring and self-measurement of blood pressure at home. J Health Sci 50:113–119CrossRef
Metadata
Title
Effects of percutaneous coronary intervention on the ambulatory blood pressure of patients with hypertension and coronary heart disease
Authors
Jing Yang
Xuming Yang
Wei Liu
Tingting Cao
Publication date
01-12-2015
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2015
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-014-1198-9

Other articles of this Issue 4/2015

Irish Journal of Medical Science (1971 -) 4/2015 Go to the issue

Original Article

Child and adolescent Down syndrome-associated leukaemia: the Irish experience

Original Article

Effects of different etomidate doses on intraoperative somatosensory-evoked potential monitoring

Original Article

Youth mental health in deprived urban areas: a Delphi study on the role of the GP in early intervention

Original Article

A comparative analysis of the occupational energy expenditure of radiologists versus clinicians

Original Article

The effect of Glutathione-S-transferases in the susceptibility to bladder cancer

Original Article

Influence of age and gender on Doppler index of diastolic function in Chinese hypertensive patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits